Rumer Willis, daughter of actors Bruce Willis and Demi Moore, has reportedly shifted her focus toward proactive health management following the diagnosis of frontotemporal dementia (FTD) in her father. In light of the family history, Willis underwent several comprehensive health examinations, including an APOE genetic test designed to assess potential hereditary risks associated with conditions like Alzheimer’s disease. Willis stated that her primary motivation for these screenings was to accumulate as much detailed health data as possible.
Speaking about the results, she disclosed that her assessment score was in the range of 3 to 4, which she characterized as relatively average. According to the actress, this outcome suggests a measurable risk profile but does not indicate immediate alarm. The emphasis from Willis was placed on the empowerment derived from knowledge.
She indicated that having comprehensive health information provides a greater sense of control over one’s well-being. The ongoing attention to her health underscores a commitment to understanding potential hereditary factors within the prominent Willis lineage. The steps taken by Rumer Willis reflect a growing trend among individuals with familial predispositions to neurological disorders—prioritizing detailed testing and understanding genetic markers.
Her decision to pursue this level of diagnostic clarity positions her approach as one of informed self-advocacy.
Topics: #willis #genetic #her
